IS5245A - Lyfjablanda úr ómeprasól - Google Patents

Lyfjablanda úr ómeprasól

Info

Publication number: IS5245A
Authority: IS; Iceland
Prior art keywords: omeprazole; pharmaceutical preparation; pharmaceutical; preparation
Prior art date: 1997-05-28

Application number

IS5245A

Other languages

English (en)

Other versions

IS2856B (is

Inventor

Erickson Magnus

Josefsson Lars

Original Assignee

Astra Aktiebolag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1997-05-28

Filing date

1999-11-11

Publication date

1999-11-11

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=20407122&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IS5245(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1999-11-11 Application filed by Astra Aktiebolag filed Critical Astra Aktiebolag

1999-11-11 Publication of IS5245A publication Critical patent/IS5245A/is

2013-11-15 Publication of IS2856B publication Critical patent/IS2856B/is

Links

SUBDBMMJDZJVOS-UHFFFAOYSA-N 5-methoxy-2-{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl}-1H-benzimidazole Chemical compound N=1C2=CC(OC)=CC=C2NC=1S(=O)CC1=NC=C(C)C(OC)=C1C SUBDBMMJDZJVOS-UHFFFAOYSA-N 0.000 title 1
229960000381 omeprazole Drugs 0.000 title 1
239000000825 pharmaceutical preparation Substances 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/167—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface
- A61K9/1676—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface having a drug-free core with discrete complete coating layer containing drug
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

Health & Medical Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
General Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Epidemiology (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)

IS5245A 1997-05-28 1999-11-11 Lyfjablanda úr ómeprasól IS2856B (is)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
SE9702000A SE9702000D0 (sv)	1997-05-28	1997-05-28	New pharmaceutical formulation
PCT/SE1998/000922 WO1998053803A1 (en)	1997-05-28	1998-05-18	Pharmaceutical formulation of omeprazole

Publications (2)

Publication Number	Publication Date
IS5245A true IS5245A (is)	1999-11-11
IS2856B IS2856B (is)	2013-11-15

Family

ID=20407122

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IS5245A IS2856B (is)	1997-05-28	1999-11-11	Lyfjablanda úr ómeprasól

Country Status (40)

Country	Link
US (1)	US6090827A (is)
EP (1)	EP0984773B1 (is)
JP (1)	JP4649001B2 (is)
KR (1)	KR100540721B1 (is)
CN (1)	CN1123338C (is)
AR (1)	AR012698A1 (is)
AT (1)	ATE234078T1 (is)
AU (1)	AU722879B2 (is)
BR (1)	BR9809484A (is)
CA (1)	CA2290531C (is)
CZ (1)	CZ298972B6 (is)
DE (1)	DE69812089T2 (is)
DK (1)	DK0984773T3 (is)
DZ (1)	DZ2494A1 (is)
EE (1)	EE03903B1 (is)
EG (1)	EG24044A (is)
ES (1)	ES2195342T3 (is)
HR (1)	HRP980260B1 (is)
HU (1)	HU229154B1 (is)
ID (1)	ID24654A (is)
IL (1)	IL132895A0 (is)
IS (1)	IS2856B (is)
MA (1)	MA26497A1 (is)
MY (1)	MY122298A (is)
NO (1)	NO328100B1 (is)
NZ (1)	NZ500886A (is)
PL (1)	PL194634B1 (is)
PT (1)	PT984773E (is)
RS (1)	RS49629B (is)
RU (1)	RU2207121C2 (is)
SA (1)	SA98190304B1 (is)
SE (1)	SE9702000D0 (is)
SI (1)	SI0984773T1 (is)
SK (1)	SK286625B6 (is)
TN (1)	TNSN98068A1 (is)
TR (1)	TR199902890T2 (is)
TW (1)	TW575435B (is)
UA (1)	UA71541C2 (is)
WO (1)	WO1998053803A1 (is)
ZA (1)	ZA984178B (is)

Families Citing this family (50)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6699885B2 (en)	1996-01-04	2004-03-02	The Curators Of The University Of Missouri	Substituted benzimidazole dosage forms and methods of using same
US5840737A (en)	1996-01-04	1998-11-24	The Curators Of The University Of Missouri	Omeprazole solution and method for using same
US6645988B2 (en)	1996-01-04	2003-11-11	Curators Of The University Of Missouri	Substituted benzimidazole dosage forms and method of using same
US6489346B1 (en) *	1996-01-04	2002-12-03	The Curators Of The University Of Missouri	Substituted benzimidazole dosage forms and method of using same
US6096340A (en)	1997-11-14	2000-08-01	Andrx Pharmaceuticals, Inc.	Omeprazole formulation
US6174548B1 (en) *	1998-08-28	2001-01-16	Andrx Pharmaceuticals, Inc.	Omeprazole formulation
EP1004305B1 (en) *	1998-04-20	2011-09-28	Eisai R&D Management Co., Ltd.	Stabilized compositions containing benzimidazole-type compounds
SE9803772D0 (sv) *	1998-11-05	1998-11-05	Astra Ab	Pharmaceutical formulation
SE9902386D0 (sv) *	1999-06-22	1999-06-22	Astra Ab	New formulation
US6245913B1 (en)	1999-06-30	2001-06-12	Wockhardt Europe Limited	Synthetic procedure for 5-methoxy-2-[(4-methoxy-3,5-dimethyl-2-pyridinyl)-methylthio]-IH-benzimidazole hydrochloride and its conversion to omeprazole
ES2168043B1 (es)	1999-09-13	2003-04-01	Esteve Labor Dr	Forma farmaceutica solida oral de liberacion modificada que contiene un compuesto de bencimidazol labil en medio acido.
DE60036014T2 (de)	1999-10-20	2008-04-30	Eisai R&D Management Co., Ltd.	Methode zur stabilisierung von benzimidazol-verbindungen
US20040092511A1 (en) *	1999-12-10	2004-05-13	Billstein Stephan Anthony	Pharmaceutical combinations and their use in treating gastrointestinal and abdominal viscera disorders
US20020192299A1 (en) *	2000-12-28	2002-12-19	Rajneesh Taneja	Pharmaceutical compositions of a non-enteric coated proton pump inhibitor with a carbonate salt and bicarbonate salt combination
JP2002234842A (ja) *	2001-02-09	2002-08-23	Kyowa Yakuhin Kogyo Kk	内服腸溶性製剤
MXPA04007169A (es) *	2002-01-25	2004-10-29	Santarus Inc	Suministro transmucosal de inhibidores de bomba de protones.
US20040082618A1 (en) *	2002-07-03	2004-04-29	Rajneesh Taneja	Liquid dosage forms of acid labile drugs
FR2843121B3 (fr)	2002-08-02	2004-09-10	Rhodia Chimie Sa	Agent ignifugeant, procede de preparation et l'utilisation de cet agent
US20040121004A1 (en) *	2002-12-20	2004-06-24	Rajneesh Taneja	Dosage forms containing a PPI, NSAID, and buffer
US20070243251A1 (en) *	2002-12-20	2007-10-18	Rajneesh Taneja	Dosage Forms Containing A PPI, NSAID, and Buffer
US20040146558A1 (en) *	2003-01-28	2004-07-29	Kyowa Pharmaceutical Co., Ltd.	Oral enteric-coated preparation
RU2359671C2 (ru) *	2003-01-29	2009-06-27	Такеда Фармасьютикал Компани Лимитед	Способ получения препарата с покрытием
BRPI0407074A (pt) *	2003-01-29	2006-01-24	Takeda Pharmaceutical	Método para produção de uma preparação revestida, preparação revestida, e, método para melhorar a dissolução do cloridreto de pioglitazona de uma preparação revestida com cloridreto de pioglitazona
JP4567340B2 (ja) *	2003-01-29	2010-10-20	武田薬品工業株式会社	被覆製剤の製造方法
CN1761465B (zh) *	2003-01-29	2010-10-13	武田药品工业株式会社	制备被覆制剂的方法
JP2006518751A (ja) *	2003-02-20	2006-08-17	サンタラスインコーポレイティッド	胃酸の急速かつ持続的な抑制のための新規製剤、オメプラゾール制酸剤複合体−即時放出物
US20050042277A1 (en) *	2003-07-17	2005-02-24	Irukulla Srinivas	Pharmaceutical compositions having a swellable coating
US8993599B2 (en)	2003-07-18	2015-03-31	Santarus, Inc.	Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
US20070292498A1 (en) *	2003-11-05	2007-12-20	Warren Hall	Combinations of proton pump inhibitors, sleep aids, buffers and pain relievers
CN1311824C (zh) *	2004-04-21	2007-04-25	常州市第四制药厂有限公司	奥美拉唑肠溶微粒制剂及制备方法
US8815916B2 (en) *	2004-05-25	2014-08-26	Santarus, Inc.	Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
US8906940B2 (en) *	2004-05-25	2014-12-09	Santarus, Inc.	Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
ES2324354T3 (es) *	2005-07-29	2009-08-05	Rottapharm S.P.A.	Combinacion terapeutica de itriglumida e inhibidores de la bomba de protones en el tratamiento de trastornos gastrointestinales y relacionados.
CA2654402A1 (en) *	2006-06-01	2007-12-06	Adel Penhasi	Multiple unit pharmaceutical formulation
KR101436516B1 (ko) *	2007-07-23	2014-09-02	주식회사태평양제약	코팅된 펠렛을 함유하는 현탁정 및 이의 제조방법
WO2009041765A1 (en) *	2007-09-28	2009-04-02	Ctc Bio, Inc.	Pharmaceutical composition containing esomeprazole
MX2010010479A (es) *	2008-03-28	2011-02-22	Ferrer Int	Capsula para la prevencion de enfermedades cardiovasculares.
EP2334378B1 (en)	2008-08-19	2014-04-09	XenoPort, Inc.	Prodrugs of methyl hydrogen fumarate, pharmaceutical compositions thereof, and methods of use
US9597292B2 (en)	2012-08-22	2017-03-21	Xenoport, Inc.	Oral dosage forms of methyl hydrogen fumarate and prodrugs thereof
JP2015527372A (ja)	2012-08-22	2015-09-17	ゼノポート，インコーポレイティド	副作用を低減させるモノメチルフマレートおよびそのプロドラッグの投与方法
CN102961356A (zh) *	2012-12-11	2013-03-13	山西云鹏制药有限公司	一种含奥美拉唑的蓝色肠溶片剂的制备方法
WO2014160633A1 (en)	2013-03-24	2014-10-02	Xenoport, Inc.	Pharmaceutical compositions of dimethyl fumarate
TW201516020A (zh)	2013-09-06	2015-05-01	Xenoport Inc	（ｎ，ｎ－二乙基胺甲醯基）甲基（２ｅ）丁－２－烯－１，４－二酸甲酯之晶形、合成方法及用途
US20150079180A1 (en) *	2013-09-18	2015-03-19	Xenoport, Inc.	Nanoparticle compositions of dimethyl fumarate
US9999672B2 (en)	2014-03-24	2018-06-19	Xenoport, Inc.	Pharmaceutical compositions of fumaric acid esters
EP3288556A4 (en)	2015-04-29	2018-09-19	Dexcel Pharma Technologies Ltd.	Orally disintegrating compositions
US10076494B2 (en)	2016-06-16	2018-09-18	Dexcel Pharma Technologies Ltd.	Stable orally disintegrating pharmaceutical compositions
US20230058473A1 (en)	2020-01-27	2023-02-23	Towa Pharmaceutical Co., Ltd.	Esomeprazole oral preparation and method for producing the same
KR102432084B1 (ko)	2021-11-16	2022-08-12	알리코제약(주)	S-오메프라졸을 함유하는 안정성이 개선되고 소형화된 정제
EP4598528A1 (en)	2022-10-04	2025-08-13	Arsenil Zabirnyk	Inhibition of aortic valve calcification

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
SE7804231L (sv) *	1978-04-14	1979-10-15	Haessle Ab	Magsyrasekretionsmedel
SE8301182D0 (sv) *	1983-03-04	1983-03-04	Haessle Ab	Novel compounds
GB2189698A (en) *	1986-04-30	1987-11-04	Haessle Ab	Coated omeprazole tablets
YU48263B (sh) *	1991-06-17	1997-09-30	Byk Gulden Lomberg Chemische Fabrik Gmbh.	Postupak za dobijanje farmaceutskog preparata na bazi pantoprazola
JPH05255088A (ja) *	1991-11-05	1993-10-05	Yoshitomi Pharmaceut Ind Ltd	抗潰瘍剤含有製剤
JP2669446B2 (ja) *	1992-03-23	1997-10-27	信越化学工業株式会社	医薬品コーティング液用原料粉粒体
FR2692146B1 (fr) *	1992-06-16	1995-06-02	Ethypharm Sa	Compositions stables de microgranules d'omeprazole gastro-protégés et leur procédé d'obtention.
JPH0733659A (ja) *	1992-07-17	1995-02-03	Yoshitomi Pharmaceut Ind Ltd	抗潰瘍剤含有製剤
SE9301830D0 (sv) *	1993-05-28	1993-05-28	Ab Astra	New compounds
SE9302395D0 (sv) *	1993-07-09	1993-07-09	Ab Astra	New pharmaceutical formulation
SE9302396D0 (sv) *	1993-07-09	1993-07-09	Ab Astra	A novel compound form
PT1078628E (pt) *	1994-07-08	2009-01-27	Astrazeneca Ab	Forma de dosagem em comprimidos com unidades múltiplas
SE9500422D0 (sv) *	1995-02-06	1995-02-06	Astra Ab	New oral pharmaceutical dosage forms

1997
- 1997-05-28 SE SE9702000A patent/SE9702000D0/xx unknown
1998
- 1998-05-14 AR ARP980102246A patent/AR012698A1/es not_active Application Discontinuation
- 1998-05-14 HR HR980260A patent/HRP980260B1/xx not_active IP Right Cessation
- 1998-05-15 MA MA25077A patent/MA26497A1/fr unknown
- 1998-05-15 TW TW87107541A patent/TW575435B/zh not_active IP Right Cessation
- 1998-05-18 EE EEP199900540A patent/EE03903B1/xx not_active IP Right Cessation
- 1998-05-18 SK SK1590-99A patent/SK286625B6/sk not_active IP Right Cessation
- 1998-05-18 RS YUP-608/99A patent/RS49629B/sr unknown
- 1998-05-18 ID IDW991448A patent/ID24654A/id unknown
- 1998-05-18 NZ NZ500886A patent/NZ500886A/en not_active IP Right Cessation
- 1998-05-18 DZ DZ980104A patent/DZ2494A1/xx active
- 1998-05-18 US US09/077,717 patent/US6090827A/en not_active Expired - Lifetime
- 1998-05-18 PL PL98337237A patent/PL194634B1/pl unknown
- 1998-05-18 ES ES98924700T patent/ES2195342T3/es not_active Expired - Lifetime
- 1998-05-18 CA CA002290531A patent/CA2290531C/en not_active Expired - Lifetime
- 1998-05-18 RU RU99126869/14A patent/RU2207121C2/ru not_active IP Right Cessation
- 1998-05-18 AT AT98924700T patent/ATE234078T1/de active
- 1998-05-18 TR TR1999/02890T patent/TR199902890T2/xx unknown
- 1998-05-18 WO PCT/SE1998/000922 patent/WO1998053803A1/en not_active Ceased
- 1998-05-18 CZ CZ0420299A patent/CZ298972B6/cs not_active IP Right Cessation
- 1998-05-18 PT PT98924700T patent/PT984773E/pt unknown
- 1998-05-18 UA UA99116247A patent/UA71541C2/uk unknown
- 1998-05-18 JP JP50056299A patent/JP4649001B2/ja not_active Expired - Fee Related
- 1998-05-18 EP EP98924700A patent/EP0984773B1/en not_active Expired - Lifetime
- 1998-05-18 KR KR1019997011083A patent/KR100540721B1/ko not_active Expired - Fee Related
- 1998-05-18 CN CN98805564A patent/CN1123338C/zh not_active Expired - Fee Related
- 1998-05-18 ZA ZA984178A patent/ZA984178B/xx unknown
- 1998-05-18 IL IL13289598A patent/IL132895A0/xx not_active IP Right Cessation
- 1998-05-18 DE DE69812089T patent/DE69812089T2/de not_active Expired - Lifetime
- 1998-05-18 SI SI9830433T patent/SI0984773T1/xx unknown
- 1998-05-18 HU HU0002182A patent/HU229154B1/hu not_active IP Right Cessation
- 1998-05-18 BR BR9809484-0A patent/BR9809484A/pt not_active Application Discontinuation
- 1998-05-18 AU AU76803/98A patent/AU722879B2/en not_active Ceased
- 1998-05-18 DK DK98924700T patent/DK0984773T3/da active
- 1998-05-21 TN TNTNSN98068A patent/TNSN98068A1/fr unknown
- 1998-05-25 EG EG56898A patent/EG24044A/xx active
- 1998-05-27 MY MYPI98002355A patent/MY122298A/en unknown
- 1998-07-19 SA SA98190304A patent/SA98190304B1/ar unknown
1999
- 1999-11-11 IS IS5245A patent/IS2856B/is unknown
- 1999-11-26 NO NO19995809A patent/NO328100B1/no not_active IP Right Cessation

Also Published As

Publication number	Publication date
RS49629B (sr)	2007-08-03
TR199902890T2 (xx)	2000-02-21
SA98190304B1 (ar)	2006-10-11
HUP0002182A3 (en)	2003-02-28
NO328100B1 (no)	2009-12-07
MY122298A (en)	2006-04-29
HRP980260A2 (en)	1999-02-28
KR20010013104A (ko)	2001-02-26
ID24654A (id)	2000-07-27
PT984773E (pt)	2003-07-31
SK286625B6 (sk)	2009-02-05
CN1123338C (zh)	2003-10-08
AU7680398A (en)	1998-12-30
EP0984773A1 (en)	2000-03-15
HK1025744A1 (en)	2000-11-24
JP2002500665A (ja)	2002-01-08
BR9809484A (pt)	2000-06-20
SK159099A3 (en)	2000-06-12
NZ500886A (en)	2001-11-30
ATE234078T1 (de)	2003-03-15
KR100540721B1 (ko)	2006-01-10
CZ298972B6 (cs)	2008-03-26
NO995809L (no)	2000-01-28
PL194634B1 (pl)	2007-06-29
AU722879B2 (en)	2000-08-10
JP4649001B2 (ja)	2011-03-09
EG24044A (en)	2008-04-13
SI0984773T1 (en)	2003-10-31
EE9900540A (et)	2000-06-15
ES2195342T3 (es)	2003-12-01
AR012698A1 (es)	2000-11-08
IS2856B (is)	2013-11-15
UA71541C2 (uk)	2004-12-15
SE9702000D0 (sv)	1997-05-28
EE03903B1 (et)	2002-12-16
EP0984773B1 (en)	2003-03-12
RU2207121C2 (ru)	2003-06-27
TW575435B (en)	2004-02-11
WO1998053803A1 (en)	1998-12-03
CA2290531A1 (en)	1998-12-03
DK0984773T3 (da)	2003-07-07
CZ420299A3 (cs)	2000-05-17
DE69812089D1 (de)	2003-04-17
HRP980260B1 (en)	2003-10-31
CA2290531C (en)	2006-12-12
US6090827A (en)	2000-07-18
TNSN98068A1 (fr)	2005-03-15
PL337237A1 (en)	2000-08-14
ZA984178B (en)	1998-11-30
HUP0002182A2 (hu)	2002-05-29
IL132895A0 (en)	2001-03-19
CN1258217A (zh)	2000-06-28
YU60899A (sh)	2002-06-19
MA26497A1 (fr)	2004-12-20
DE69812089T2 (de)	2004-03-04
DZ2494A1 (fr)	2003-01-25
HU229154B1 (en)	2013-09-30
NO995809D0 (no)	1999-11-26

Publication	Publication Date	Title
IS5245A (is)	1999-11-11	Lyfjablanda úr ómeprasól
NO994757D0 (no)	1999-09-30	FramgangsmÕte for oral administrasjon av proteiner
EE200100259A (et)	2002-12-16	Moksifloksatsiini farmatseutiline preparaat
CY2012029I1 (el)	2015-08-05	Νεα μορφη της s-ομεπραζολης
IS5953A (is)	2001-05-25	Lyfjablöndur úr örgerðum eplerenonum
ID23874A (id)	2000-05-25	Obat
DK1466615T3 (da)	2009-08-31	Farmaceutisk præparat
NO995251D0 (no)	1999-10-27	FremgangsmÕte for administrering av haloterapi
EE04154B1 (et)	2003-10-15	Omeprasooli valmistamise meetod
FI953887L (fi)	1996-06-14	Kefaklorin farmaseuttisia formulaatioita
DK0868911T3 (da)	2003-01-20	Rapamycinpræparater til oral indgivelse
DE69926012D1 (de)	2005-08-04	Arzneizubereitungen
ID16781A (id)	1997-11-13	Formulasi-formulasi farmasi
ID29294A (id)	2001-08-16	Komposisi farmasi
DK1041966T3 (da)	2003-10-06	Farmaceutiske præparater omfattende zafirlukast
DE69906934D1 (de)	2003-05-22	Arzneizubereitungen
EP1142589A4 (en)	2002-04-24	Medicinal preparations
FI951155L (fi)	1995-09-15	Farmaseuttinen valmiste
ID23531A (id)	2000-04-27	Komposisi farmasi
FI974235A0 (fi)	1997-11-14	Ny bestaemningsmetod
FI3862U1 (fi)	1999-03-18	Geelimuotoinen farmaseuttinen valmiste
SK1380U (sk)	1997-02-05	Farmaceutický preparát
BR9612652A (pt)	1999-07-20	Forma de administração farmacêutica
BR1100755A (pt)	2006-05-09	composição farmacêutica
ID21180A (id)	1999-05-06	Senyawa-senyawa farmasi